← All diseases

Disease Atlas / Disease detail

Usher syndrome

An atlas of autosomal-recessive sensorineural hearing loss, retinitis pigmentosa, balance dysfunction, genetic diagnosis, and sensory rehabilitation.

Usher syndrome · hereditary deafness-retinitis pigmentosa syndrome

MONDO:0019501Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · b20abb2b5e24

Disease class
Usher syndrome causes hearing loss with progressive vision loss.
Core mechanism
Hearing loss is sensorineural and arises from the inner ear.
Genes or cause
Vision loss results from retinitis pigmentosa.
Typical features
Night blindness can be followed by progressive peripheral-field loss.
Variability
Types I, II, and III differ in hearing, balance, and onset.
Diagnosis
Multiple genes cause it with autosomal-recessive inheritance.
Management
Diagnosis integrates hearing, retinal, balance, and genetic testing.
Treatment and research
Genetic counseling supports family recurrence-risk interpretation.
Reading evidence
Hearing aids and cochlear implants support communication in selected patients.
Key caution
Low-vision, orientation, mobility, and communication services begin early.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Usher syndrome causes hearing loss with progressive vision loss.

Night blindness can be followed by progressive peripheral-field loss.

How the disease works

Hearing loss is sensorineural and arises from the inner ear.

Vision loss results from retinitis pigmentosa.

Why experiences vary

Types I, II, and III differ in hearing, balance, and onset.

Diagnosis and management

Multiple genes cause it with autosomal-recessive inheritance.

Treatment status

Diagnosis integrates hearing, retinal, balance, and genetic testing.

Genetic counseling supports family recurrence-risk interpretation.

Reading clinical trials

No current cure reverses all sensory loss.

Topics for a clinical visit

Genotype, hearing, visual fields, balance, and accessibility needs require review.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.